# Siemens and Akesobio partner on biopharma automation project

Siemens signed a commercial contract and technical agreement with Akeso Sano Pharma, a subsidiary of Akesobio, to provide automation, digitalization and intelligence solutions for Akesobio's Bay Area Science and Technology Park in China. The project involves a 40,000L stainless steel monoclonal antibody production line.

- Type: Contract
- Announced: 2022-02-24
- Where: Akesobio Bay Area Science and Technology Park, China, China
- Status: announced
- Capacity: 40,000L stainless steel process equipment
- Products: process automation systems, digitalization solutions, monoclonal antibody drugs
- Sectors: [Automation and Robotics](https://endata.com/sectors/automation-robotics.md), [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Siemens](https://endata.com/companies/301.md) (supplier)
- [Akesobio](https://endata.com/companies/61256.md) (customer)
- [Akeso Sano Pharma](https://endata.com/companies/61257.md) (customer)

## Sources

- [pharmaceutical-tech.com](https://www.pharmaceutical-tech.com/pressreleases/siemens-and-akesobio-join-forces-to-drive-forward-the-development-of-bio-pharma), 2022-02-24: "Digital technology is the key for biopharmaceutical companies to meet the challenges."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.